Cite

HARVARD Citation

    Topp, M. et al. (2021). Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma. British journal of haematology. pp. 388-398. [Online]. 
  
Back to record